Abstract
Tumour necrosis factor (TNF) was first described1 as a factor in the serum of mice injected with tubercle bacilli (BCG) and several days later with lipopolysaccharide (LPS). The gene encoding TNF has recently been cloned and pure recombinant human TNF is now available2,3. TNF is known for its in vivo antitumour effect and in vitro cytotoxicity on certain transformed cell lines4,5. Similarities in amino acid sequence and biological activity to lymphotoxin and cachectin have been reported2,6, and very recently a growth-factor-like activity oh diploid fibroblasts was observed7. There is no similarity between these proteins and interferons (IFNs), which are also induced during in vivo induction of TNF8. Here we describe the antiviral activity of pure recombinant human TNF in a typical in vitro antiviral assay which we discovered while investigating the possible role of TNF as an inducer of IFN.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carswell, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 72, 3666–3670 (1975).
Pennica, D. et al. Nature 312, 722–729 (1984).
Aggarwal, B. B. et al. J. biol. Chem. 260, 2345–2354 (1985).
Helson, L., Green, S., Carswell, E. & Old, L. J. Nature 258, 731–732 (1985).
Ruff, M. R. & Gifford, G. E. Infect. Immun. 31, 380–385 (1981).
Beutler, B., Milsark, I. W. & Cerami, A. C. Science 229, 869–871 (1985).
Vilcek, J. et al. J. exp. Med. 162, 632–643 (1986).
Younger, J. S. & Stinebring, W. R. Nature 208, 456–458 (1965).
Kohase, M., Henriksen-De Stefano, D., May, L. T., Vilcek, J. & Sehgal, P. B. Cell 45, 659–666 (1986).
Old, L. J. Science 230, 630–632 (1985).
Laemmli, U. K. Nature 227, 680–685 (1970).
Fed. Reg. 4.11.1977, 42FR57749, FDA.
Merlin, G., Revel, M. & Wallach, D. Analyt. Biochem. 110, 190–196 (1980).
Bradford, M. M. Analyt. Biochem. 72, 248–254 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mestan, J., Digel, W., Mittnacht, S. et al. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323, 816–819 (1986). https://doi.org/10.1038/323816a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/323816a0
This article is cited by
-
MAIT cells, guardians of skin and mucosa?
Mucosal Immunology (2021)
-
A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors
Cellular & Molecular Immunology (2021)
-
Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV
Scientific Reports (2016)
-
Microbubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in rats
Scientific Reports (2016)
-
Production of porcine TNFα by ADAM17-mediated cleavage negatively regulates porcine reproductive and respiratory syndrome virus infection
Immunologic Research (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
